Consolidated Balance Sheets (USD $)	Mar. 31, 2012		Dec. 31, 2011		Mar. 31, 2011	Dec. 31, 2010
Cash and cash equivalents	$ 572		$ 456		$ 722	$ 560
Total Assets	572		456
Accounts payable and accrued expenses	8,349		28,400
Deposits - Shareholder	200,000		200,000
Advances from related parties	716,236		685,434
Note payable - related party	396,000		396,000
Preferred stock		[1]		[1]
Capital stock	36,720	[2]	36,720	[2]
Additional paid-in capital	2,423,952		2,423,952
Deficit accumulated during the development stage	(4,451,644)		(4,366,010)
Total Stockholders' Equity (Deficiency)	(1,990,972)		(1,905,338)
Total Liabilities and Stockholders' Equity/(Deficit)	$ 572		$ 456

[1] 5,000,000 shares authorized;$.001 par value; 1,000,000 shares issued and none outstanding

[2] $.001 par value; 100,000,000 shares authorized; 36,719,854 shares issued and outstanding at March 31, 2012; and December 31, 2011, respectively